Factors Important to Older Adults Who Disagree With a Deprescribing Recommendation.

Weir, Kristie Rebecca; Shang, Jenny; Choi, Jae; Rana, Ruchi; Vordenberg, Sarah E (2023). Factors Important to Older Adults Who Disagree With a Deprescribing Recommendation. JAMA Network Open, 6(10), e2337281. American Medical Association 10.1001/jamanetworkopen.2023.37281

Preview

Text weir_2023_oi_231093_1696279219.84103.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview

IMPORTANCE

Little is known about why older adults decline deprescribing recommendations, primarily because interventional studies rarely capture the reasons.

OBJECTIVE

To examine factors important to older adults who disagree with a deprescribing recommendation given by a primary care physician to a hypothetical patient experiencing polypharmacy.

DESIGN, SETTING, AND PARTICIPANTS

This online, vignette-based survey study was conducted from December 1, 2020, to March 31, 2021, with participants 65 years or older in the United Kingdom, the US, Australia, and the Netherlands. The primary outcome of the main study was disagreement with a deprescribing recommendation. A content analysis was subsequently conducted of the free-text reasons provided by participants who strongly disagreed or disagreed with deprescribing. Data were analyzed from August 22, 2022, to February 12, 2023.

MAIN OUTCOMES AND MEASURES

Attitudes, beliefs, fears, and recommended actions of older adults in response to deprescribing recommendations.

RESULTS

Of the 899 participants included in the analysis, the mean (SD) age was 71.5 (4.9) years; 456 participants (50.7%) were men. Attitudes, beliefs, and fears reported by participants included doubts about deprescribing (361 [40.2%]), valuing medications (139 [15.5%]), and a preference to avoid change (132 [14.7%]). Valuing medications was reported more commonly among participants who strongly disagreed compared with those who disagreed with deprescribing (48 of 205 [23.4%] vs 91 of 694 [13.1%], respectively; P < .001) or had personal experience with the same medication class as the vignette compared with no experience (93 of 517 [18.0%] vs 46 of 318 [12.1%], respectively; P = .02). Participants shared that improved communication (225 [25.0%]), alternative strategies (138 [15.4%]), and consideration of medication preferences (137 [15.2%]) may increase their agreement with deprescribing. Participants who disagreed compared with those who strongly disagreed were more interested in additional communication (196 [28.2%] vs 29 [14.2%], respectively; P < .001), alternative strategies (117 [16.9%] vs 21 [10.2%], respectively; P = .02), or consideration of medication preferences (122 [17.6%] vs 15 [7.3%], respectively; P < .001).

CONCLUSIONS AND RELEVANCE

In this survey study, older adults who disagreed with a deprescribing recommendation were more interested in additional communication, alternative strategies, or consideration of medication preferences compared with those who strongly disagreed. These findings suggest that identifying the degree of disagreement with deprescribing could be used to tailor patient-centered communication about deprescribing in older adults.

Interest & Impact

Downloads

3 since deposited on 13 Oct 2023
3 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item